In this article, we catch up with the past. Just to make sure that we have everyone on the same virtual page. Acomplia (generic name rimonabant) has been an authorised medication in the EU since June 2006 for use in …

Acomplia produced disappointing results in slowing progression of coronary artery disease in patients and it significantly raised the risk of anxiety and depression, according to a report in the April 2 issue of the Journal of the American Medical Association.
More …

Pondering over weight loss? With obesity spreading far and wide, entrapping young and old alike in its ambit, it is important to find a solution to this health hazard. Weight loss pills which have made their presence felt in the …

Acomplia is not for everyone. In the following lines I’ll try making things clear on how to use acomplia.

People with liver or kidney disease should not use Acomplia. This is because the liver metabolizes the drug and the kidneys excrete …